Results 141 to 150 of about 56,319 (181)
Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents. [PDF]
Wang YK +13 more
europepmc +1 more source
Some MSM Blood Donors Move from a Lifetime Deferral to a One Year Ban “Finally” or “Not Good Enough”? [PDF]
Printz, Heather
core +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
AIDS, 1992
This review describes some of the virus-cell relationships that might contribute to the state of latency observed in HIV infection. Viruses use many mechanisms to persist in their host, and the molecular interactions evoked by the virus and the cell on each other can influence the outcome of an infection.
D P, Bednarik, T M, Folks
openaire +2 more sources
This review describes some of the virus-cell relationships that might contribute to the state of latency observed in HIV infection. Viruses use many mechanisms to persist in their host, and the molecular interactions evoked by the virus and the cell on each other can influence the outcome of an infection.
D P, Bednarik, T M, Folks
openaire +2 more sources
Cellular Latency in HIV-1 Infection
Clinics in Laboratory Medicine, 1994There are multiple levels of transcriptional regulation that a cell can bring to bear on either native cellular genes or integrated proviral genes. One such level of regulation is inducible sequence-specific transcriptional factors, such as NF-kappa B, which have been extensively investigated with respect to the HIV-1 LTR.
M A, Laughlin, R J, Pomerantz
openaire +2 more sources
Underlying mechanisms of HIV-1 latency
Virus Genes, 2017Similarly to other retroviruses, HIV-1 integrates its genome into the cellular chromosome. Expression of viral genes from the integrated viral DNA could then be regulated by the host genome. If the infected cell suppresses viral gene expression, the virus will undergo latency.
Bizhan Romani, Elham Allahbakhshi
openaire +2 more sources
Molecular mechanisms of HIV-1 proviral latency
Expert Review of Anti-infective Therapy, 2005While great strides have been made in the treatment of HIV infection with highly active antiretroviral therapy, an actual cure remains out of grasp. One confounding factor is the persistence of a small population of infected cells containing transcriptionally silent but reactivatable HIV proviruses.
Dwayne, Bisgrove +3 more
openaire +2 more sources
Therapeutics for HIV-1 reactivation from latency
Current Opinion in Virology, 2013Intensive combined antiretroviral therapy successfully suppresses HIV-1 replication and AIDS disease progression making infection manageable, but it is unable to eradicate the virus that persists in long-lived, drug-insensitive and immune system-insensitive reservoirs thus asking for life-long treatments with problems of compliance, resistance ...
Marco, Sgarbanti, Angela, Battistini
openaire +2 more sources
Humanized Mouse Models of HIV-1 Latency
Current HIV Research, 2011The existence of long-lasting cellular reservoirs of HIV-1 is one of the major hurdles in developing effective anti-retroviral therapies. These latently infected cells and tissues efficiently evade immune responses and remain dormant until activated, upon which they can generate a productive HIV-1 infection.
Duyne, Rachel V +5 more
openaire +2 more sources
The multifactorial nature of HIV-1 latency
Trends in Molecular Medicine, 2004HIV-1 can avoid host immune responses and antiretroviral drugs through the latent infection of resting memory CD4(+) T cells. Recently, latent viral genomes have been shown to reside within the introns of active host genes. Therefore, latency is not simply due to an inaccessibility of the integrated proviruses to the transcriptional machinery.
Kara, Lassen +4 more
openaire +2 more sources

